Hosted By
Senate Democrats are poised to pass a reconciliation bill next week that would, among other things, allow the federal government to "negotiate" prescription drug prices and more.
Sally C. Pipes, president and CEO of the Pacific Research Institute, spoke on the bill's impact and how it will affect inflation and the future of drug development. Sally has recently published op-eds on how the reconciliation package will undermine drug research in the likes of the Washington Examiner, Newsmax, and the Pittsburgh Post-Gazette. Find her article here.
Brooke Livingston, the Fiance of Officer Matthew Mistretta, joined John and discussed how Officer Mistretta is facing seven years in prison for arresting a...
What if you could finally cut through the confusion of contractor bids—and never risk a nightmare project again? In this interview, John Grishpole of...
HR 3 Rush To Reason January 13 2021 by John Rush
